Literature DB >> 786518

Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

A Alberti, G Realdi, F Tremolada, G P Spina.   

Abstract

This paper describes immunofluorescence studies on liver cell surface localization of hepatitis B surface antigen (HBsAg) and of IgG in acute and chronic hepatitis and in cirrhosis. In acute hepatitis B, HBsAg was found at the surface of hepatocytes in an early phase of the disease, but not during the recovery. This finding is consistent with the hypothesis that immune reactions to HBsAg may be responsible for the liver cell lysis. In HBsAg-positive chronic hepatitis and cirrhosis the antigen was found in the cytoplasm, but not on the surface of the hepatocytes, while in HBsAg-negative cases the antigen could not be detected in the liver cells. Both in HBsAg-positive and in HBsAg-negative chronic active hepatitis (CAH) and cryptogenic cirrhosis IgG bound to the membrane of the hepatocytes could be detected, suggesting a role of antibodies in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786518      PMCID: PMC1541400     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Changes in the solubility of immunoglobulins after fluorescent labeling and its influence on immunofluorescent techniques.

Authors:  W Arnold; H von Mayersbach
Journal:  J Histochem Cytochem       Date:  1972-12       Impact factor: 2.479

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

4.  Letter: HBAg on liver-cell surface in viral hepatitis.

Authors:  A Alberti; G Realdi; F Tremolada; P Cadrobbi
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

5.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde
Journal:  Br J Exp Pathol       Date:  1974-10

6.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

8.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

9.  Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patients.

Authors:  U Hopf; W Arnold; K H Meyer zum Büschenfelde; E Förster; J P Bolte
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  26 in total

1.  Detection of hepatitis A antigen by immunofluorescence.

Authors:  L R Mathiesen; S M Feinstone; R H Purcell; J A Wagner
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

Authors:  N El Sheikh; C G Osman; H Cullens; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

Review 3.  Antigens of the human liver.

Authors:  I G McFarlane; B M Wojcicka; R Williams
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

4.  T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.

Authors:  A Alberti; G Realdi; F Bortolotti; A M Rigoli
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Disordered immunoregulatory functions in patients with chronic active hepatitis.

Authors:  A Nonomura; M Tanino; H Kurumaya; G Ohta; Y Kato; K Kobayashi
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

6.  Cellular immunity to the hepatitis B virion in acute hepatitis type B.

Authors:  G Fattovich; A Alberti; C Crivellaro; P Pontisso; F Noventa; G Realdi
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Effects of adenine arabinoside on cellular immune responses in patients with chronic hepatitis B.

Authors:  I Hyodo; G Yamada; K Manabe; H Okushin; M Mizuno; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-06

8.  Anti-LSP antibodies in acute liver disease.

Authors:  R Meliconi; A Perperas; D Jensen; A Alberti; I G McFarlane; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

9.  Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus.

Authors:  M K Mackenjee; P Kiepiela; R Cooper; H M Coovadia
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

10.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.